Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension

BACKGROUND: Pulmonary arterial hypertension (PAH) and breast cancer disproportionately affect women. BMPR2 (bone morphogenetic protein receptor type 2) mutations, the most common genetic cause of heritable PAH, also exert tumor-suppressive functions, but their role in linking these diseases remains unclear. METHODS: We combined bioinformatic, epidemiologic, and experimental approaches. Public cancer datasets were mined for BMPR2 alterations. In vivo, mammary tumor development and pulmonary hemodynamics were assessed in female Bmpr2(+/

  • Toro, V.
  • Mougin, M.
  • Brossat, C.
  • Jambon-Barbara, C.
  • Hlavaty, A.
  • Guay, C. A.
  • El Kabbout, R.
  • Bilodeau, C.
  • Grobs, Y.
  • Martineau, S.
  • Breuils-Bonnet, S.
  • Abi-Sleimen, A.
  • Ruffenach, G.
  • Boucherat, O.
  • Bisserier, M.
  • Provencher, S.
  • Bonnet, S.
  • Montani, D.
  • Khouri, C.
  • Potus, F.

Keywords

  • Bmpr2
  • animal model
  • breast cancer
  • inflammation
  • pulmonary hypertension
  • tumors
Publication details
DOI: 10.1161/circulationaha.125.079067
Journal: Circulation
Work Type: Original
Access number: 41603037
More information
chevron-down